Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients
Introduction: A higher percentage of sustained virologic response (SVR) has been reported with the introduction of direct-acting antivirals (DAAs) to the treatment of hepatitis C in recent years. However, there are still relatively limited data on the effectiveness and safety of the use of DAAs in h...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Turkish |
Published: |
Galenos Yayinevi
2019-12-01
|
Series: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
Subjects: | |
Online Access: | http://mjima.org/text.php?&id=171 |